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Clinical presentation, treatment, and outcome of dacryocystitis in
rabbits: a retrospective study of 28 cases (2003-2007)
Abstract
Objective: To document the clinical presentation, diagnostics, treatment, and clinical outcome of rabbits
with dacryocystitis.
Materials and methods: This retrospective study included 28 rabbits diagnosed with dacryocystitis.
Available records of clinical and ophthalmological examinations, bacteriological samplings, diagnostic
imaging, and treatment were reviewed. A telephone survey of the owners was conducted to evaluate
recovery and recurrences.
Results: The mean age of the 28 rabbits presenting with ocular discharge from the nasolacrimal duct was
4.4 years. In 25 rabbits (89%), dacryocystitis was a unilateral finding. No underlying cause could be
determined in 10 animals (35%). Dental malocclusion was observed in 14 rabbits (50%) and rhinitis in
two animals (7%), with one animal showing both symptoms (4%). One rabbit (4%) presented with
panophthalmitis. Most animals (96%) received topical antibiotic treatment. If necessary, additional
topical (acetylcysteine, vitamin A ointment, nonsteroidals) or systemic treatment (antibiotics,
nonsteroidals, paramunity inducer, and glucocorticoids) was provided. The mean duration of therapy
was 5.8 weeks. The nasolacrimal duct was flushed in 27 of 31 affected eyes (87%). Dentistry was
performed in 80% of the animals suffering from malocclusion. Regarding the clinical outcome, 12
animals (43%) showed complete recovery, eight rabbits (28%) were euthanized, three (11%) died due to
unrelated causes, and three (11%) were lost to follow-up. Two rabbits (7%) continue to display signs of
dacryocystitis and are being treated symptomatically by the owners.
Conclusions: This study reports the clinical presentation, treatment, and outcome of dacryocystitis in
rabbits and outlines the importance of examination of the oral cavity, diagnostic imaging, and
bacteriologic sampling.
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Abstract 
Objective To document the clinical presentation, diagnostics, treatment and clinical outcome of rabbits 
with dacryocystitis.  
Materials and Methods This retrospective study included 28 rabbits diagnosed with dacryocystitis. 
Available records of clinical and ophthalmological examinations, bacteriological samplings, diagnostic 
imaging and treatment were reviewed. A telephone survey of the owners was conducted to evaluate 
recovery and recurrences. 
Results The mean age of the 28 rabbits presenting with ocular discharge from the nasolacrimal duct 
was 4.4 years. In 25 rabbits (89%), dacryocystitis was a unilateral finding. No underlying cause could 
be determined in 10 animals (35%). Dental malocclusion was observed in 14 rabbits (50%) and rhinitis 
in 2 animals (7%), with one animal showing both symptoms (4%). One rabbit (4%) presented with 
panophthalmitis.  
Most animals (96%) received topical antibiotic treatment. If necessary, additional topical 
(acetylcysteine, vitamin A ointment, non-steroidals) or systemic treatment (antibiotics, non-steroidals, 
paramunity inducer and glucocorticoids) was provided. The mean duration of therapy was 5.8 weeks. 
The nasolacrimal duct was flushed in 27 of 31 affected eyes (87%). Dentistry was performed in 80% of 
the animals suffering from malocclusion. 
Regarding the clinical outcome, twelve animals (43%) showed complete recovery, eight rabbits (28%) 
were euthanized, three (11%) died due to unrelated causes and three (11%) were lost to follow up. Two 
rabbits (7%) continue to display signs of dacryocystitis and are being treated symptomatically by the 
owners. 
Conclusions The present study reports the clinical presentation, treatment and outcome of 
dacryocystitis in rabbits and outlines the importance of examination of the oral cavity, diagnostic 
imaging and bacteriologic sampling. 
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Introduction 
Rabbits have for many years been widely used as laboratory animals by pharmaceutical companies and 
research institutes. In recent years however, they have become increasingly popular as pet animals and 
are therefore often encountered in veterinary small animal practices. Rabbits are presented to 
veterinarians mainly due to parasitic, dental or infectious diseases but also because of ophthalmic 
disorders. An investigative study on 586 New Zealand White rabbits living in commercial breeding 
facilities revealed an incidence rate of 9.6% for ophthalmic diseases.(1) The predominant ophthalmic 
disease observed was blepharitis, followed by cataract and conjunctivitis. Dacryocystitis was found in 
only 0.2% of the examined animals. A clinical study on 344 rabbits at the Veterinary Medical Hospital, 
University of California, Davis showed a comparable incidence rate of 10% for ophthalmic diseases, 
with 73% of these animals showing clinical signs of dacryocystitis.(2) Therefore, ocular discharge is a 
common reason for presenting rabbits to veterinary services and can relate not only to conjunctivitis 
but also to dacryocystitis and nasolacrimal duct infection.  
Dacryocystitis is an inflammation of the lacrimal sac that is often accompanied by a nasolacrimal duct 
obstruction. A common cause for this disease in the rabbit is an underlying dental problem that blocks 
the nasolacrimal duct. Less frequently, a primary bacterial infection can be established as the eliciting 
factor. Diagnosis is made clinically during examination by the expression of purulent material from the 
nasolacrimal punctum with pressure on the skin beneath the medial canthus or by flushing of the 
nasolacrimal duct. In some cases, the lacrimal sac is even visually and palpably distended with pus. 
Secondary findings include conjunctivitis, corneal edema and keratitis due to the permanent purulent 
discharge on the cornea.(3, 4) 
So far, several studies have been published, concerning the microbiology and specific anatomy of the 
nasolacrimal duct of rabbits with dacryocystitis.(1, 2, 4-13) However, to the best of our knowledge, 
information on the clinical outcome of treated patients affected by this disease is scarce. In this 
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retrospective study, 28 rabbits diagnosed with dacryocystitis were followed regarding the clinical signs, 
diagnostics, treatment and clinical outcome. 
 
Materials and Methods 
Dacryocystitis was diagnosed in twenty-eight rabbits referred to the Veterinary Teaching Hospital of 
the Vetsuisse Faculty, University of Zurich, with ocular discharge between March 2003 and May 2007. 
All rabbits fulfilled the following inclusion criteria: (1) display of purulent discharge from the 
nasolacrimal duct and (2) no history of previous dacryocystitis. Data collected included the findings of 
clinical and ophthalmic examination, bacteriological sampling (if available), diagnostic imaging (if 
available), the treatment, and clinical outcome. A telephone survey of the owners was conducted in 
order to determine each animal’s progress beyond the final clinical examination at our clinic.  
Statistical analysis 
Data editing and all the statistical analysis was performed using Stata Software (StataCorp., 2009; Stata 
Statistical Software: Release 10.1; College Station, TX, USA:StataCopr LP). Analyses were carried out 
using the tab2 and the oneway command in STATA version 10 (StataCorp, 2007) for categorical 
analysis and analysis of variance. A p-value of   0.05 was considered significant.  
 
Results 
From the database, twenty-eight rabbits with dacryocystitis were identified and observed. Sixteen of 
the presented animals were crossbred pet rabbits. Other breeds represented were eight dwarf and four 
lop eared rabbits. The animal population consisted of twenty males, seven females and one rabbit of 
unknown gender. The mean age was 4.4 years, ranging from 0.5 to 11 years. Twenty-three (82%) of the 
animals were presented due to ocular discharge (Fig. 1). In the remaining five (18%) animals, 
dacryocystitis was a secondary finding diagnosed during clinical examination. Three rabbits were 
presented for unrelated reasons not pertinent to the presence of dacryocystitis, one rabbit showed a 
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head tilt and respiratory disease and one animal was referred to the teaching hospital with 
panophthalmitis.  The clinical features, duration of treatment, cause, recovery, recurrence and clinical 
outcome are summarized in Table 1. 
Clinical examination 
Clinical ophthalmic and oral examination was performed on all rabbits. Purulent discharge from the 
nasolacrimal duct was observed in all patients and primarily occurred unilaterally (25/28, 89%). Other 
associated pathologic findings were conjunctivitis (15/28, 53%), nasal discharge (8/28, 28%) (Fig. 2), 
keratitis (6/28, 21%), periorbital swelling (5/28, 18%) and panophthalmitis (1/28, 4%). In many 
animals, examination of the oral cavity revealed dental disorders with malocclusion (15/28, 53%).  
Diagnostic imaging 
Due to the financial limitations of the owners, diagnostic imaging of the head was carried out in only 
eight of the fifteen rabbits displaying dental disorders. Diagnostic imaging consisted of mere 
radiographs. Unfortunately, dacryocystorhinography could not be conducted in any of the animals. 
Radiological changes were seen in four rabbits and consisted of alveolar periosteitis, tooth root 
infection, periosteal new bone formation and osteolysis of the maxillary bone (Fig. 3). 
Bacteriological sampling 
Swab specimens of the purulent discharge were taken in eight rabbits at the clinical examination or 
during nasolacrimal flushing. Placed in a commercially available transport device, they were sent to the 
bacteriological laboratory of the Vetsuisse Faculty, University of Zurich, for further culturing. In four 
rabbits, one pathogen (E.coli, Staphyloccus intermedius, Staphylococcus sp. and Gramnegative Cocci 
without further specification, respectively) was found in the nasolacrimal discharge. In two rabbits, 
E.coli was found together with Staphylococcus sp. or Streptococcus sp., respectively. No bacterial 
growth was detected in two samples.  
Treatment 
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The mean duration of therapy was 5.8 weeks, ranging from 1 day to 64 weeks. The duration of 
treatment had a significant influence regarding the clinical outcome (p = 0.0008). The mean treatment 
time in the rabbits with healing was 2.9 weeks compared to a mean treatment time of 8.3 weeks in the 
animals with no recovery. 
Most (27/28, 96%) rabbits were initially treated with topical antibiotic therapy: aminoglycosides 
combined with non-steroidal anti-inflammatory agents (14/27), fluoroquinolones (9/27), 
chloramphenicol (2/27) and triple antibiotic combinations (aminoglycoside/Polymyxin B/bacitracin) 
(2/27). Depending on the severity of the clinical signs, acetylcysteine (4/27), vitamin A ointment (4/27) 
or non-steroidal agents (3/27) were topically applied.  
Many animals required systemic treatment (13/28, 54%). Antibiotics were administered in ten rabbits, 
alone (4/10) or in combination with non-steroidal anti-inflammatory drugs (5/10) and glucocorticoids 
(1/10), respectively. Antibiotics used for systemic therapy were as follows: fluoroquinolones (6/10), 
chloramphenicol (2/10), aminoglycosides (1/10) and macrolides (1/10). In two rabbits, the systemic 
treatment exclusively consisted of non-steroidal inflammatory drugs. In one very mildly affected rabbit 
displaying rhinitis, the sole treatment for the dacryocystitis was flushing of the nasolacrimal duct with 
physiological saline. Additionally, a paramunity inducer (chemically inactivated parapoxvirus) was 
systemically administered for the treatment of the rhinitis. 
Systemic treatment had a significantly negative association on the recovery (p = 0.022) and the 
outcome (p= 0.029) of these rabbits with dacryocystitis. 
Nasolacrimal flushing with 0.9% sodium chloride was conducted in twenty-seven (87%) of the thirty-
one affected eyes. If necessary, inhalation anesthesia with isoflurane was administered for timorous 
rabbits not used to handling. Twelve ducts were patent and fourteen obstructed, with one flushing not 
being specified. Successive flushing with medical agents was carried out in seven eyes. The main agent 
used for flushing was a fluoroquinolone antibiotic alone (4/7) or accompanied by acetylcysteine (1/7). 
One duct was flushed with a combination of an aminoglycoside antibiotic and a non-steroidal drug 
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accompanied by aceylcysteine and one flushing was accomplished with acetylcysteine alone. Flushing 
and patency of the duct had no significant influence on recovery or the outcome in this study group (p 
> 0.05 in all cases).  
Dentistry with incisor and/or molar trimming was performed in most (12/15) of the rabbits suffering 
from malocclusion.  
Three rabbits (11%) were euthanized at the first clinical examination due to the severity of the 
underlying disease causing the dacryocystitis. 
Follow-up examinations 
Thirteen (52%) of the twenty-five remaining animals returned to the Veterinary Medical Teaching 
Hospital of the Vetsuisse Faculty, University of Zurich, for follow-up examinations. Most rabbits 
(5/13) were seen for one check-up only. In some cases, two (2/13), three (4/13), or four or more (2/13) 
follow-up examinations were necessary. Additional radiography and bacteriological sampling were 
conducted in one and four rabbits, respectively.  At the second check-up, one rabbit was euthanized due 
to medical non-response and worsening of the symptoms, and one rabbit with an additional phlegmone 
died while being hospitalized at the Vetsuisse Faculty, University of Zurich. In two rabbits, the 
treatment remained unchanged during the treatment period. Many modifications were made to the 
treatment due to a poor response to therapy in the other nine animals. Number of rabbits with changes 
in therapy was as follows: systemic and topical modifications in 5 rabbits, systemic modifications in 2 
rabbits and topical modification in 1 rabbit, respectively.  
Topical antibiotic treatment was changed in six rabbits due to personal preference, with two of them 
additionally receiving non-steroidal and steroidal topical therapy, respectively. In three of these six 
animals, this was done even though the detected microorganisms were sensitive to the formerly used 
antibiotics in repeated microbial testing.  
In seven animals, systemic treatment was initiated or changed. Additional therapy included antibiotics 
in one rabbit and antibiotics accompanied by a non-steroidal anti-inflammatory agent in two animals. 
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In the other four rabbits, the systemic antibiotics were changed with a supplemental administration of a 
non-steroidal anti-inflammatory agent in two of them.  
Of these nine rabbits requiring changes in therapy, one patient suffering from the secondary formation 
of a corneal abscess and uveitis was enucleated and one rabbit was euthanized due to medical non-
response and worsening of the symptoms at a later check up. 
Modifications to the therapy (topical and systemic) had no significant influence regarding recovery or 
the outcome. Due to the many alterations in treatment, statistics regarding the specific agents could not 
be established. 
Telephone survey 
Of the twenty-eight rabbits, five (18%) animals were euthanized at the Vetsuisse Faculty, University of 
Zurich, one (4%) animal died as an in-patient and three (11%) animals were lost to follow-up. The 
owners of the remaining nineteen (68%) animals were surveyed about the progress of the disease to 
assist in determining long-term outcome. Nine animals have subsequently been checked by the 
referring veterinarians, with three of them later being euthanized due to clinical non-response to the 
therapy.  
Clinical outcome 
Of the twenty-eight rabbits treated for dacryocystitis at the Vetsuisse Faculty, University of Zurich, 
twelve (43%) animals showed complete recovery after an average treatment time of 2.9 weeks. Two of 
these animals showed recurrences after several months that resolved with additional treatment. Of the 
remaining sixteen rabbits, eight (28%) were euthanized after an average treatment time of 3.1 weeks, 
three (11%) died due to unrelated causes during the treatment period and three (11%) were lost to 
follow-up. Two (7%) animals continue to display discharge and are presently being treated by the 
owners 
Findings regarding the cause of dacryocystitis and the corresponding clinical outcome are summarized 
in Table 2. The most important reason for the development of this disease identified in our study was 
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dental disorders with fourteen (50%) affected animals with no other signs and one rabbit (4%) were 
dental disorders as well as signs of rhinitis were observed. No cause could be found in 10 (35%) 
rabbits, while 2 (7%) animals showed signs of rhinitis and one (4%) animal suffered from 
panophthalmitis. 
In the statistical analysis comparing age, topical and systemic therapy, lavage and patency of the 
nasolacrimal duct, the cause, recovery, recurrence and outcome, only the administration of systemic 
treatment and the duration of therapy and had a significant effect. Both parameters had a negative 
association on the outcome and the systemic treatment additionally on the recovery. 
 
Discussion 
The two main causes known to induce dacryocystitis in rabbits are dental disorders and rhinitis. As also 
seen in this study with 53% affected animals, most cases of dacryocystitis are secondary to an 
underlying dental disease accompanied by a blockage of the nasolacrimal duct and resultant secondary 
bacterial infection. This blockage is based on a predisposition of the rabbit due to specific anatomical 
properties that differ from other animals such as dogs, cats, horses, and ungulates.(2, 3, 5, 6, 10, 11, 13) 
The rabbit displays only one single nasolacrimal punctum, which is located in the anteromedial aspect 
of the lower eyelid. The duct is very slender and consists of a tortuous route with two sudden 
constrictions. One is a proximal bend when the duct enters the maxillary bone, and the other narrowing 
is located more distally at the base of the incisor tooth roots. Additionally, the duct passes very close to 
the roots of premolar and incisor teeth, has a rich vascular and lymphatic supply, undulations of the 
epithelium and a small opening into the nasal vestibule.  
The second well known cause for dacryocystitis is a primary bacterial infection.(6, 8-11) Pasteurella 
sp. is the best studied bacterial pathogen in rabbit nasolacrimal ducts, but Staphylococcus aureus is also 
often encountered in diseased rabbits with conjunctivitis or dacryocystitis. Other bacteria such as 
Staphylococcus sp., Moraxella sp., Oligella urethralis, Pseudomonas, and Streptococcus viridans have 
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been detected in the nasolacrimal ducts of rabbits with epiphora but also in healthy control animals. 
They are therefore considered to be part of the resident flora of the nasolacrimal duct. It is very 
unfortunate that not all patients in this study were sampled for bacteriological involvement, especially 
the animals suffering from rhinitis. Therefore, data on bacterial involvement and sensitivity to the 
antibiotics used for treatment was very scarce. We recommend routine bacteriological sampling in all 
patients with dacryocystitis to adjust the antibiotic treatment. 
A temporarily or permanent reduced immune status could also promote the development of a primary 
bacterial infection, since many potentially pathogenic bacteria are commensals in the nasolacrimal duct 
of healthy rabbits, as described earlier. In 35% of the rabbits in our study, no underlying cause could be 
established. This group of rabbits mainly consisted of healthy animals (7/10) but also included three 
rabbits suffering from unrelated severe diseases. A reduced immune status could have been a possible 
eliciting factor, although no blood work or further investigations were conducted to confirm this 
hypothesis. This could lead to a consequential bacterial infection in those rabbits that were in 
apparently good health. 
In this study, no significant differences regarding recovery and the outcome could be established when 
comparing the different causes of dacryocystitis. Further prospective studies are needed to evaluate this 
disease, especially in rabbits without obvious signs of a primary disease such as dental problems or 
rhinitis.  
As seen in this retrospective study, financial restraints often preclude further diagnostics and/or 
intensive treatment of pet rabbits in Switzerland. In all twenty-eight cases, merely twelve bacteriologic 
samples and nine radiographs were taken throughout the treatment period and no 
dacryocystorhinography could be conducted. Therefore, determination of etiology and prognosis was 
challenging.  
The significant negative influence of systemic treatment regarding the recovery and the outcome 
indicates that the prognosis of severely affected animals requiring systemic therapy is guarded. It was 
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also statistically demonstrated, that the more prolonged the treatment period, the poorer the outcome in 
this disease. The mean treatment time in the rabbits that healed was 2.9 weeks, compared to a mean 
treatment time of 8.3 weeks in the animals with no recovery. This shows a strong tendency towards a 
poor prognosis if any complications in the treatment are experienced. 
An interesting finding in this study was that the patency of the nasolacrimal duct was not a significant 
indicator for a positive outcome in this disease. In 57% of patients with no recovery, the duct remained 
blocked. This was also seen, however, in 36% of the rabbits with complete recovery.  
In this study, four of the twelve animals with complete recovery showed epiphora as a minor 
complication. This could be explained by scarring and fibrosis of the delicate duct during the presence 
of inflammation, even though in three of these rabbits the nasolacrimal ducts were flushed during 
treatment and were patent. 
Recurrence of the purulent discharge originating in the nasolacrimal duct was seen in three animals. 
The eliciting cause for dacryocystitis in two of these animals was dental disorders alone and dental 
disorders accompanied by rhinitis, respectively. Since dental disorders are usually a chronic problem, 
the relapses were not surprising in these cases. No cause could be found in the third rabbit, which was 
otherwise healthy with a good occlusion of the teeth. It suffered from several relapses between 2003 
and 2007. When the owner was questioned about the progress of the disease at the end of 2007, the 
rabbit had been healthy without any signs of dacryocystitis for several months and was therefore 
considered healed.  
To find out more about etiology, prognosis and most importantly about a more successful therapy, 
further prospective studies are needed. This would be especially helpful, since in the animals of the 
present study, the therapy was often changed on personal experience. This could also be explained due 
to the little literature that exists about dacryocystitis in rabbits. The authors also think that the 
complexity of this disease is often underestimated in rabbits. 
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In conclusion, the most common treatment for dacryocystitis included the empirical use of topical 
antibacterial drugs and flushing of the nasolacrimal duct. Unfortunately, many veterinarians 
underestimate the often poor response to topical treatment with antibiotics and the resultant chronic 
problem that can develop, due to underlying severe diseases. Considering the specific anatomical 
condition of the oculodental region in rabbits, it is important to examine the oral cavity thoroughly and 
to use diagnostic imaging and bacteriological sampling in evaluating the etiology, treatment and 
prognosis. 
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Figure 1. Ocular discharge emerging from the nasolacrimal duct of a rabbit with dacryocystitis.  
Figure 2. Nasal discharge in a rabbit with dacryocystitis. 
Figure 3. (a, b) Radiographs of the skull of a rabbit displaying dacryocystitis due to a dental disease. 
Severe soft tissue swelling with osseous involvement (arrow) and alveolar periosteitis of the first and 
second cheek teeth (arrow head) is seen. In the lateral picture, an uneven occlusal plane is additionally 
visible (*). 
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Table 1. Clinical features, diagnostics, duration of treatment, cause, recovery, recurrence and outcome of rabbits with dacryocystitis 
Case 
# 
Age 
(years) 
Eye       
affected 
Lavage of 
nasolacrimal 
duct 
Patency of 
nasolacrimal 
duct* 
Bacteriolo-
gical samples 
(noted if 
done) 
Diagnostic 
imaging    
(noted if 
done) 
Total 
duration of 
treatment      
(weeks) Cause of disease Recovery Recurrence Outcome  
1 0.75 OS Yes Yes   2 Dental disorders Yes None Healed 
2 1 OS No    2 Dental disorders Yes None Healed 
3 5 OS Yes No   2 Dental disorders Yes None Healed 
4 8 OS Yes No -> Yes   9 Unknown Yes None Healed (after enucleation) 
5 5 OS Yes Yes Yes Yes 4 Unknown Yes None Healed (epiphora still present) 
6 2 OS Yes Not stated   2 Dental disorders Yes None Healed (epiphora still present) 
7 4 OD Yes Yes   2 Unknown Yes None Healed (epiphora still present) 
8 1 OS/OD Yes Yes   1 Unknown Yes None Healed (epiphora still present) 
9 6 OD Yes No  Yes 2 Dental disorders Yes None Healed  
10 9 OD Yes No   3 Dental disorders Yes None Healed (after 9 month) 
11 0.5 OS/OD Yes Yes   2 
Dental disorders/ 
Rhinitis Yes Yes Healed 
12 3 OD Yes No   4 Unknown Yes Yes Healed  
13 6 OS Yes No Yes Yes 4 Dental disorders Yes Yes Discharge  
14 6 OD Yes No Yes Yes 64 Dental disorders No  Discharge  
15 1 OS Yes Yes Yes  43 Dental disorders No  Euthanasia 
16 2 OD Yes Yes -> No Yes  5 Dental disorders No  Euthanasia 
17 10 OD Yes No   0.15 Panophthalmitis No  Euthanasia 
18 5 OS Yes No  Yes 0.15 Dental disorders No  Euthanasia 
19 6 OS No   Yes 0.6 Rhinitis No  Euthanasia 
20 1 OD Yes Yes Yes  8 Unknown No  Euthanasia 
21 2 OS Yes Yes   1 Dental disorders No  Euthanasia 
22 4 OS Yes No Yes Yes 5 Unknown No  Euthanasia 
23 3 OS/OD Yes No -> Yes Yes  6 Unknown No  Died during treatment period** 
24 6 OS No    2 Rhinitis No  Died during treatment period** 
25 4 OS Yes No   0.5 Dental disorders No  Died during treatment period** 
26 3 OS Yes Yes Yes Yes 14 Dental disorders ltf  Lost to follow-up 
27 11 OS Yes No   not stated Unknown ltf  Lost to follow-up 
28 6 OD Yes Yes Yes  not stated Unknown ltf  Lost to follow-up 
* -> showing the progress during treatment,        ** -> died due to an unrelated cause 
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Table 2. Clinical outcome regarding the cause of dacryocystitis   
Cause of disease Recovery No recovery 
Death due to 
unrelated cause 
Lost to 
follow-up 
(number of affected 
animals) [%] [%] [%] [%] 
     
Dental disorders 6 6 1 1 
(n=14) [43%] [43%] [7%] [7%] 
     
Dental disorders and 
rhinitis 1    
(n=1) [100%]    
     
Rhinitis  1 1  
(n=2)  [50%] [50%]  
     
Panophthalmitis  1   
(n=1)  [100%]   
          
Unknown cause 5 2 1 2 
(n=10) [50%] [20%] [10%] [20%] 
     
Total number of 
rabbits 12 10 3 3 
(n=28) [43%] [35%] [11%] [11%] 
 
 
 
Figure 1. 
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Figure 2. 
 
 
Figure 3a. 
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Figure 3b. 
